MILTEFOSINE

MILTEFOSINE was reported 388 times

MILTEFOSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BIOPSY CORNEA 1 0.3333
1 AMOEBIC BRAIN ABSCESS 2 0.2500
2 BALAMUTHIA INFECTION 6 0.2069
3 ACANTHAMOEBA KERATITIS 7 0.1892
4 CILIARY BODY DEGENERATION 1 0.1111
5 ACANTHAMOEBA INFECTION 15 0.0798
6 GOOD SYNDROME 1 0.0556
7 ENCEPHALITIS PROTOZOAL 3 0.0536
8 MENINGOENCEPHALITIS AMOEBIC 3 0.0517
9 MUCOCUTANEOUS LEISHMANIASIS 6 0.0492
10 RICKETTSIOSIS 1 0.0455
11 KWASHIORKOR 1 0.0417
12 AMNIOTIC MEMBRANE GRAFT 1 0.0385
13 ACUTE HAEMORRHAGIC LEUKOENCEPHALITIS 1 0.0278
14 VISCERAL LEISHMANIASIS 20 0.0277
15 KERATOUVEITIS 1 0.0270
16 ALEXIA 2 0.0247
17 KERATOPLASTY 1 0.0238
18 LEISHMANIASIS 5 0.0172
19 ABDOMINAL WALL OEDEMA 1 0.0159
20 QUADRANTANOPIA 2 0.0153
21 BACTERIA SPUTUM IDENTIFIED 1 0.0132
22 ANAL RASH 1 0.0104
23 CARDIAC VALVE VEGETATION 5 0.0103
24 SCEDOSPORIUM INFECTION 7 0.0099
25 CORNEAL TOXICITY 1 0.0090
26 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 2 0.0086
27 ATROPHY OF GLOBE 1 0.0078
28 CYTOKINE INCREASED 1 0.0074
29 BLASTOMYCOSIS 3 0.0062
30 PRODUCT INEFFECTIVE 4 0.0051
31 CORNEAL GRAFT REJECTION 1 0.0048
32 POST PROCEDURAL OEDEMA 1 0.0043
33 CRANIOFACIAL DEFORMITY 1 0.0043
34 AMOEBIASIS 1 0.0043
35 CORNEAL NEOVASCULARISATION 1 0.0040
36 CORNEAL THINNING 1 0.0039
37 CENTRAL NERVOUS SYSTEM NECROSIS 1 0.0036
38 OCULAR SURFACE DISEASE 1 0.0036
39 SUBCUTANEOUS NODULE 1 0.0035
40 KERATITIS 10 0.0033
41 INFECTIOUS PLEURAL EFFUSION 5 0.0033
42 NEPHRITIC SYNDROME 1 0.0032
43 CORNEAL INFILTRATES 1 0.0032
44 DRUG LEVEL CHANGED 2 0.0032
45 CORNEAL PERFORATION 2 0.0032
46 VASOGENIC CEREBRAL OEDEMA 2 0.0028
47 HERPES SIMPLEX REACTIVATION 1 0.0026
48 LYMPHANGITIS 2 0.0025
49 HYPOPYON 2 0.0024
50 HYPOTONY OF EYE 1 0.0024
51 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
52 KAPOSI'S SARCOMA 1 0.0020
53 BRAIN ABSCESS 5 0.0020
54 VISCERAL CONGESTION 1 0.0020
55 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
56 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
57 CHIKUNGUNYA VIRUS INFECTION 1 0.0018
58 LUNG CONSOLIDATION 5 0.0018
59 PLEOCYTOSIS 1 0.0017
60 NEURODEGENERATIVE DISORDER 1 0.0016
61 REFLEXES ABNORMAL 1 0.0015
62 ULCERATIVE KERATITIS 4 0.0015
63 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
64 FINGER AMPUTATION 1 0.0014
65 LOCAL REACTION 1 0.0013
66 ENCEPHALITIS 9 0.0013
67 CORNEAL TRANSPLANT 1 0.0013
68 CSF PROTEIN INCREASED 1 0.0012
69 JC VIRUS TEST POSITIVE 1 0.0012
70 ATONIC SEIZURES 1 0.0012
71 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
72 PUNCTATE KERATITIS 1 0.0011
73 OTOTOXICITY 2 0.0011
74 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
75 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 57 0.0010
76 HAEMOPHILUS INFECTION 1 0.0010
77 CD4 LYMPHOCYTES DECREASED 2 0.0009
78 CORNEAL DISORDER 2 0.0009
79 NOSOCOMIAL INFECTION 2 0.0009
80 OCULAR TOXICITY 1 0.0009
81 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
82 STREPTOCOCCAL SEPSIS 1 0.0008
83 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
84 ELECTROLYTE IMBALANCE 9 0.0008
85 CORNEAL OPACITY 1 0.0007
86 NECROSIS 4 0.0007
87 POST HERPETIC NEURALGIA 1 0.0007
88 SUPERINFECTION 1 0.0007
89 PALLIATIVE CARE 1 0.0007
90 DRUG LEVEL DECREASED 6 0.0006
91 MYCOBACTERIAL INFECTION 1 0.0006
92 PSEUDOMONAL SEPSIS 1 0.0006
93 FOOD INTERACTION 1 0.0006
94 TRANSPLANT DYSFUNCTION 1 0.0006
95 BLOOD HIV RNA INCREASED 1 0.0006
96 PATHOGEN RESISTANCE 5 0.0005
97 MACULAR OEDEMA 3 0.0005
98 SACROILIITIS 1 0.0005
99 MULTI-ORGAN DISORDER 1 0.0005
100 DISEASE RECURRENCE 24 0.0005
101 PHOTOSENSITIVITY REACTION 8 0.0005
102 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
103 LIPODYSTROPHY ACQUIRED 1 0.0005
104 HYPERTRANSAMINASAEMIA 3 0.0004
105 PANNICULITIS 1 0.0004
106 SELF ESTEEM DECREASED 1 0.0004
107 DRUG RESISTANCE 10 0.0004
108 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
109 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
110 UVEITIS 5 0.0004
111 RASH MORBILLIFORM 1 0.0004
112 HAEMOTHORAX 1 0.0003
113 GASTROINTESTINAL NECROSIS 1 0.0003
114 CHEST X-RAY ABNORMAL 1 0.0003
115 LIVER INJURY 8 0.0003
116 BRAIN DEATH 1 0.0003
117 FAMILY STRESS 1 0.0003
118 BRAIN OEDEMA 4 0.0003
119 IRIDOCYCLITIS 1 0.0003
120 TRANSAMINASES INCREASED 7 0.0003
121 ASPERGILLUS INFECTION 2 0.0003
122 DEAFNESS NEUROSENSORY 1 0.0003
123 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
124 BK VIRUS INFECTION 1 0.0003
125 GRANULOMA 1 0.0003
126 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
127 AMYLASE INCREASED 1 0.0003
128 HEPATOTOXICITY 6 0.0003
129 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
130 HEMIPLEGIA 2 0.0002
131 CARDIAC FAILURE CHRONIC 1 0.0002
132 PANCYTOPENIA 13 0.0002
133 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
134 BLOOD CREATINE INCREASED 1 0.0002
135 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
136 GOUT 4 0.0002
137 VASCULAR DEVICE INFECTION 1 0.0002
138 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
139 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
140 ISCHAEMIA 1 0.0002
141 CONJUNCTIVITIS 4 0.0002
142 GASTROINTESTINAL TOXICITY 1 0.0002
143 ENTEROCOCCAL INFECTION 1 0.0002
144 ABASIA 5 0.0002
145 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
146 KLEBSIELLA INFECTION 1 0.0002
147 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
148 DRUG-INDUCED LIVER INJURY 6 0.0002
149 PRODUCT PRESCRIBING ISSUE 4 0.0002
150 EYE DISORDER 6 0.0002
151 NEPHROPATHY TOXIC 2 0.0002
152 THERAPY CESSATION 9 0.0002
153 HYPERKALAEMIA 6 0.0002
154 GASTROINTESTINAL DISORDER 15 0.0002
155 ENDOPHTHALMITIS 1 0.0002
156 RENAL FAILURE ACUTE 7 0.0002
157 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
158 OLIGURIA 1 0.0002
159 THERAPY NON-RESPONDER 7 0.0002
160 HAEMOGLOBIN ABNORMAL 1 0.0002
161 BLOOD BILIRUBIN INCREASED 4 0.0001
162 BONE MARROW FAILURE 3 0.0001
163 TREATMENT NONCOMPLIANCE 8 0.0001
164 NEPHROTIC SYNDROME 1 0.0001
165 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
166 OFF LABEL USE 122 0.0001
167 DERMATITIS BULLOUS 1 0.0001
168 RASH PUSTULAR 1 0.0001
169 RENAL FAILURE 18 0.0001
170 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
171 TREATMENT FAILURE 11 0.0001
172 LIPASE INCREASED 1 0.0001
173 DRUG INTOLERANCE 12 0.0001
174 SHOCK HAEMORRHAGIC 1 0.0001
175 POLYURIA 1 0.0001
176 RENAL IMPAIRMENT 10 0.0001
177 PYELONEPHRITIS 1 0.0001
178 DEAFNESS 3 0.0001
179 INTENTIONAL PRODUCT MISUSE 10 0.0001
180 PURPURA 1 0.0001
181 CARDIOTOXICITY 1 0.0001
182 ACUTE KIDNEY INJURY 17 0.0001
183 CONDITION AGGRAVATED 33 0.0001
184 HYPOKALAEMIA 5 0.0001
185 DEFORMITY 1 0.0001
186 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
187 SQUAMOUS CELL CARCINOMA 1 0.0001
188 HAEMATOTOXICITY 1 0.0001
189 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
190 LIVER FUNCTION TEST ABNORMAL 3 0.0001
191 PHARYNGEAL SWELLING 1 0.0001
192 THERAPY CHANGE 1 0.0001
193 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
194 BLINDNESS 4 0.0001
195 TOXICITY TO VARIOUS AGENTS 16 0.0001
196 DECREASED APPETITE 22 0.0001
197 HALLUCINATION 7 0.0001
198 BLOOD CREATININE INCREASED 6 0.0001
199 POST PROCEDURAL HAEMORRHAGE 1 0.0001
200 MYOCLONUS 1 0.0001
201 DRUG INEFFECTIVE 109 0.0001
202 RESPIRATORY FAILURE 6 0.0001
203 NEUTROPENIA 11 0.0001
204 ADVERSE DRUG REACTION 7 0.0001
205 NAUSEA 59 0.0001
206 NEUTROPHIL COUNT DECREASED 3 0.0001
207 HEPATIC ENZYME INCREASED 5 0.0001
208 SKIN LESION 2 0.0001
209 VISUAL IMPAIRMENT 9 0.0001
210 RESPIRATORY DISTRESS 2 0.0001
211 SKIN REACTION 1 0.0001
212 VOMITING 33 0.0001
213 BALANCE DISORDER 6 0.0001
214 SEPTIC SHOCK 3 0.0001
215 DISEASE PROGRESSION 8 0.0001
216 DYSGEUSIA 5 0.0001
217 APHASIA 2 0.0001
218 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
219 LYMPHOMA 1 0.0001
220 EJECTION FRACTION DECREASED 1 0.0001
221 THERAPY PARTIAL RESPONDER 1 0.0001
222 COMA 3 0.0001
223 ABSCESS 1 0.0001
224 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
225 DRUG LEVEL INCREASED 1 0.0001
226 VISUAL ACUITY REDUCED 2 0.0001
227 GAIT INABILITY 2 0.0001
228 SCAR 1 0.0001
229 NEUROTOXICITY 1 0.0001
230 PANCREATITIS 3 0.0001
231 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
232 SYNOVITIS 1 0.0001
233 END STAGE RENAL DISEASE 1 0.0001
234 EYE PAIN 3 0.0001
235 PHOTOPHOBIA 1 0.0001
236 DEHYDRATION 7 0.0001
237 PULMONARY FIBROSIS 1 0.0001
238 ACUTE RESPIRATORY FAILURE 1 0.0001
239 DISORIENTATION 2 0.0001
240 MELAENA 1 0.0000
241 DRUG INTERACTION 7 0.0000
242 PRODUCT USE ISSUE 8 0.0000
243 PRODUCT PRESCRIBING ERROR 1 0.0000
244 DIABETIC KETOACIDOSIS 1 0.0000
245 INFECTION 6 0.0000
246 HYPOGLYCAEMIA 2 0.0000
247 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
248 LEUKOPENIA 2 0.0000
249 HYPOPHAGIA 1 0.0000
250 HEPATITIS 1 0.0000
251 SKIN ULCER 1 0.0000
252 RESPIRATORY TRACT INFECTION 1 0.0000
253 ARTHRITIS 3 0.0000
254 BRADYCARDIA 2 0.0000
255 FREQUENT BOWEL MOVEMENTS 1 0.0000
256 MENTAL STATUS CHANGES 1 0.0000
257 HAEMOPTYSIS 1 0.0000
258 PANCREATIC CARCINOMA 1 0.0000
259 BLOOD POTASSIUM DECREASED 1 0.0000
260 HEPATIC FAILURE 1 0.0000
261 LACRIMATION INCREASED 1 0.0000
262 NERVOUS SYSTEM DISORDER 1 0.0000
263 PYREXIA 11 0.0000
264 HEAD INJURY 1 0.0000
265 NIGHT SWEATS 1 0.0000
266 STAPHYLOCOCCAL INFECTION 1 0.0000
267 SKIN DISORDER 1 0.0000
268 HAEMATURIA 1 0.0000
269 DELIRIUM 1 0.0000
270 CEREBRAL HAEMORRHAGE 1 0.0000
271 C-REACTIVE PROTEIN INCREASED 1 0.0000
272 HEPATIC FUNCTION ABNORMAL 1 0.0000
273 EPISTAXIS 2 0.0000
274 INTESTINAL OBSTRUCTION 1 0.0000
275 ABDOMINAL DISCOMFORT 4 0.0000
276 MENTAL DISORDER 1 0.0000
277 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
278 NEPHROLITHIASIS 1 0.0000
279 SKIN DISCOLOURATION 1 0.0000
280 DIARRHOEA 14 0.0000
281 ASTHENIA 8 0.0000
282 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
283 MALAISE 9 0.0000
284 CELLULITIS 1 0.0000
285 INFLAMMATION 1 0.0000
286 MUSCULOSKELETAL PAIN 1 0.0000
287 OEDEMA 1 0.0000
288 ANAPHYLACTIC REACTION 1 0.0000
289 WEIGHT DECREASED 5 0.0000
290 THROMBOCYTOPENIA 2 0.0000
291 HYPONATRAEMIA 1 0.0000
292 DYSPHONIA 1 0.0000
293 JOINT SWELLING 2 0.0000
294 THERAPEUTIC RESPONSE DECREASED 1 0.0000
295 ILL-DEFINED DISORDER 1 0.0000
296 RHINORRHOEA 1 0.0000
297 AMNESIA 1 0.0000
298 FEBRILE NEUTROPENIA 1 0.0000
299 ABDOMINAL PAIN UPPER 3 0.0000
300 BURNING SENSATION 1 0.0000
301 THERAPY INTERRUPTED 1 0.0000
302 CARDIAC FAILURE 1 0.0000
303 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
304 DYSPNOEA 6 0.0000
305 ANAEMIA 2 0.0000
306 GAIT DISTURBANCE 2 0.0000
307 SOMNOLENCE 2 0.0000
308 SINUSITIS 1 0.0000
309 ILLNESS 1 0.0000
310 HAEMORRHAGE 1 0.0000
311 PNEUMONIA 3 0.0000
312 SEPSIS 1 0.0000
313 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
314 ABDOMINAL PAIN 2 0.0000
315 EMOTIONAL DISTRESS 1 0.0000
316 OEDEMA PERIPHERAL 1 0.0000
317 PAIN 5 0.0000
318 DIZZINESS 4 0.0000
319 PRODUCT QUALITY ISSUE 1 0.0000
320 MEMORY IMPAIRMENT 1 0.0000
321 ARTHRALGIA 3 0.0000
322 COUGH 2 0.0000
323 HYPOAESTHESIA 1 0.0000
324 TREMOR 1 0.0000
325 FALL 2 0.0000
326 MYALGIA 1 0.0000
327 URINARY TRACT INFECTION 1 0.0000
328 DEATH 5 0.0000
329 HYPERSENSITIVITY 1 0.0000
330 PRURITUS 2 0.0000
331 HYPOTENSION 1 0.0000
332 ERYTHEMA 1 0.0000
333 HYPERTENSION 1 0.0000
334 OVERDOSE 1 0.0000
335 RASH 2 0.0000
336 WEIGHT INCREASED 1 0.0000
337 DEPRESSION 1 0.0000
338 INCORRECT DOSE ADMINISTERED 1 0.0000
339 BACK PAIN 1 0.0000
340 FATIGUE 3 0.0000
341 INSOMNIA 1 0.0000
342 HEADACHE 2 0.0000